Tricyclo[3.3.1.13,7]decan-1-aminium, N,N,N-trimethyl-, hydroxide (1:1)

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2008

Report date:

2008

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Tricyclo[3.3.1.13,7]decan-1-aminium, N,N,N-trimethyl-, hydroxide (1:1)

EC Number:

610-954-5

Cas Number:

53075-09-5

Molecular formula:

C13 H25 N O

IUPAC Name:

Tricyclo[3.3.1.13,7]decan-1-aminium, N,N,N-trimethyl-, hydroxide (1:1)

Details on test material:

- Name of test substance: Adamantyltrimethylammoniumhydroxid 20%
- Batch identification: ADTAOH 20%
- CAS No.: 53075-09-5
- Purity/composition: 20.1 g/ 100 g
- Homogeneity: The homogeneity of the test substance was ensured by mixing before preparation of the test substance solutions.
- Storage stability: The stability of the test substance under storage conditions throughout the study period was guaranteed as indicated by the sponsor, and the sponsor holds this responsibility.
- Date of production: 10 Mar 2008
- Physical state, appearance: Liquid, colorless, clear
- Storage conditions: Room temperature (N2 conditions)

Method

Species / strain

Species / strain 1

Species / strain / cell type:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Species / strain 2

Species / strain / cell type:

E. coli WP2 uvr A

Metabolic activation:

with and without

Metabolic activation system:

Phenobarbital/ß-naphthoflavone-induced rat liver S9 mix

Test concentrations with justification for top dose:

100 μg - 25000 μg/plate (SPT)
625 μg - 25000 μg/plate (PIT; Salmonella strains)
1562.5 μg - 25000 μg/plate (PIT; E. coli)

Vehicle / solvent:

- Vehicle used: water
- Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, water was used as vehicle.

Controls

Untreated negative controls:

other: Sterility control

Negative solvent / vehicle controls:

yes

Positive controls:

yes

Remarks:

W/ S9: 2-AA (2.5 µg/plate for TA 1535, TA 100, TA 1537, TA 98; 60 μg/plate for E. coli WP2 uvrA). W/o S9: MNNG (5 µg/plate for TA 1535, TA 100); NOPD (10 µg/plate for TA 98); AAC (100 µg/plate for TA 1537); 4-NQO (5 µg/plate for E. coli WP2 uvrA)

Details on test system and experimental conditions:

METHOD OF APPLICATION: Standard Plate Test (SPT) and Preincubation Test (PIT)

DURATION
- Exposure duration: 48 - 72 hours

NUMBER OF REPLICATIONS:
3 experiments (1x SPT, 2x PIT) with 3 test plates per dose or per control

DETERMINATION OF CYTOTOXICITY
- Methods: decrease in the number of revertants, clearing or diminution of the background lawn (= reduced his- or trp- background growth) and reduction in the titer

OTHER EXAMINATIONS:
Precipitation of the test material

Evaluation criteria:

The test chemical is considered positive in this assay if the following criteria are met: A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
A test substance is generally considered non-mutagenic in this test if: The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in at least two experiments carried out independently of each other.

Results and discussion

Test results

Test results 1

Species / strain:

S. typhimurium TA 1535, TA 1537, TA 98 and TA 100

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Test results 2

Species / strain:

E. coli WP2 uvr A

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Additional information on results:

TEST-SPECIFIC CONFOUNDING FACTORS:
- Precipitation: No test substance precipitation was found with and without S9 mix.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
A bacteriotoxic effect (reduced his- or trp- background growth, decrease in the number of his+ or trp+ revertants, reduction in the titer) was observed in the standard plate test depending on the strain and test conditions from about 12500 μg/plate onward. In the preincubation assay bacteriotoxicity (reduced his- or trp- background growth, decrease in the number of his+ or trp+ revertants, reduction in the titer) was observed depending on the strain and test conditions from about 5 000 μg/plate onward.

Applicant's summary and conclusion

Conclusions:

Under the experimental conditions chosen here, it is concluded that Adamantyltrimethylammoniumhydroxid 20% is not a mutagenic substance in the bacterial reverse mutation test in the absence and the presence of metabolic activation.

Executive summary:

The substance Adamantyltrimethylammoniumhydroxid 20% was tested for mutagenicity in the Salmonella typhimurium / Escherichia coli reverse mutation assay both in the standard plate test and in the preincubation test with and without the addition of a metabolizing system

(S9 mix) obtained from rat liver using the Salmonella strains TA 1535, TA 100, TA 1537, TA 98 and Escherichia coli WP2 uvrA.

The test substance did not lead to an increase in the number of revertant colonies either without S9 mix or after adding a metabolizing system in three experiments carried out independently of each other (standard plate test and preincubation assay). Besides, the results of the negative as well as the positive controls performed in parallel corroborated the validity of this study, since the values fulfilled the acceptance criteria of this study. In this study with and without S9 mix, the number of revertant colonies in the negative controls was within the range of the historical negative control data for each tester strain. In addition, the positive control substances both with and without S9 mix induced a significant increase in the number of revertant colonies within the range of the historical positive control data or above.

Conclusion: Thus, under the experimental conditions chosen here, it is concluded that Adamantyltrimethylammoniumhydroxid 20% is not a mutagenic substance in the bacterial reverse mutation test in the absence and the presence of metabolic activation.